The Cardiovascular Diagnostic and Monitoring Devices Market in the Asia Pacific was worth 368.27 million in 2019 and estimated to be growing at a CAGR of 8.14%, to reach 544.58 million by 2024.
Cardiovascular disease is a medical condition which affects the structure and function of organs associated with function of the heart and its circulation
Cardio Vascular diseases are the primary cause of death and witnessing a high rise in prevalence. There are a large number of people being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions shifting focus towards preventative healthcare.
Asia Pacific market for cardiovascular devices is majorly driven by factors such as an increasing number of people suffering from diabetes and obesity and growing risks related to hypertension, heart muscle weakening. Advancements in Technology have enabled portability features such as portability in performing various tests are also adding to the growth of the Cardiovascular Monitoring market.
However, unclear reimbursement policies, stringent government regulations for product approvals and high cost of devices are some of the major factors restraining the market growth.
This research report segmented and sub-segmented into the following categories:
By Product Type: ECG System, Event Systems, Event Monitors, Holter Monitors, Implantable Loop Recorders and ECG Management Systems.
On the basis of product type, ECG systems hold the largest share in the market and expected to maintain it’s strong in the market during the forecast period due to widespread availability and increasing preference for diagnostic devices in both developed and developing regions.
By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC.
Regionally, Asia-Pacific is estimated to be the fastest growing region due to rising awareness about the effectiveness of accessible devices in successfully curing several cardio vascular conditions and increasing healthcare spending.
Few of the prominent companies leading the majority of the shares in the APAC Cardiovascular Monitoring & Diagnostic Devices Market profiled in this report are GE Healthcare and Phillips Healthcare, Siemens Healthcare, Boston Scientific Corporation, St. Jude Medical, Inc., Nihon Kohden Corporation and Welch Allyn, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.1 ECG Systems
5.1.1.1 Resting ECG Systems
5.1.1.2 Stress ECG Systems
5.1.2 Event Monitors
5.1.3 Holter Monitors
5.1.4 Implantable Loop Recorders
5.1.5 ECG Management Systems
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Philips Healthcare
8.3 Siemens Healthcare
8.4 Boston Scientific Corporation
8.5 St. Jude Medical, Inc
8.6 Nihon Kohden Corporation
8.7 Welch Allyn, Inc.
8.8 Spacelabs Healthcare
8.9 LivaNova PLC
8.10 Hill-Rom Holdings, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
